• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乘晕宁、桂利嗪和东莨菪碱透皮贴剂对性能的影响。

The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.

作者信息

Gordon C R, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A

机构信息

Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, IDF Medical Corps, Haifa.

出版信息

J Psychopharmacol. 2001 Sep;15(3):167-72. doi: 10.1177/026988110101500311.

DOI:10.1177/026988110101500311
PMID:11565623
Abstract

We assessed the influence of dimenhydrinate, cinnarizine and transdermal scopolamine on the ability to perform simulated naval crew tasks. The effect of single doses of dimenhydrinate, 100 mg, cinnarizine, 50 mg, and one transdermal scopolamine patch on psychomotor performance was evaluated using a double-blind, placebo-controlled, randomized, crossover design in three separate studies. A total of 60 young naval crew (20 for dimenhydrinate, 15 for cinnarizine and 25 for transdermal scopolamine) underwent a battery of computerized and paper and pencil performance tests, and filled out a questionnaire on side-effects and well-being self-assessment. Dimenhydrinate significantly impaired decision reaction time and auditory digit span. Most of the subjects who took dimenhydrinate also reported a subjective decrease in well-being and general performance abilities. Cinnarizine and transdermal scopolamine did not affect performance abilities. Cinnarizine was free of significant side-effects. Dry mouth was the only significant side-effect of transdermal scopolamine. These findings could be explained by the well-known sedative properties of dimenhydrinate and not by a specific effect on any particular cognitive or motor function. Our results suggest that dimenhydrinate, 100 mg, adversely affects psychomotor function, whereas single doses of cinnarizine, 50 mg, and transdermal scopolamine appear to be free of side-effects on performance and seem to be a preferable anti-seasickness drug for use by a naval crew.

摘要

我们评估了茶苯海明、桂利嗪和透皮东莨菪碱对模拟海军船员任务执行能力的影响。在三项独立研究中,采用双盲、安慰剂对照、随机、交叉设计,评估了单剂量100毫克茶苯海明、50毫克桂利嗪和一片透皮东莨菪碱贴片对精神运动表现的影响。共有60名年轻海军船员(20名服用茶苯海明,15名服用桂利嗪,25名服用透皮东莨菪碱)接受了一系列计算机化和纸笔性能测试,并填写了一份关于副作用和幸福感自我评估的问卷。茶苯海明显著损害了决策反应时间和听觉数字广度。大多数服用茶苯海明的受试者还报告主观幸福感和总体表现能力下降。桂利嗪和透皮东莨菪碱不影响表现能力。桂利嗪没有明显的副作用。口干是透皮东莨菪碱唯一显著的副作用。这些发现可以用茶苯海明众所周知的镇静特性来解释,而不是对任何特定认知或运动功能的特定影响。我们的结果表明,100毫克茶苯海明会对精神运动功能产生不利影响,而单剂量50毫克桂利嗪和透皮东莨菪碱似乎对表现没有副作用,似乎是海军船员使用的更理想的抗晕船药物。

相似文献

1
The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.乘晕宁、桂利嗪和东莨菪碱透皮贴剂对性能的影响。
J Psychopharmacol. 2001 Sep;15(3):167-72. doi: 10.1177/026988110101500311.
2
A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.桂利嗪与东莨菪碱透皮贴剂预防海军船员晕船的比较:一项双盲、随机、交叉研究。
Clin Neuropharmacol. 2012 Jan-Feb;35(1):37-9. doi: 10.1097/WNF.0b013e31823dc125.
3
The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.透皮东莨菪碱对模拟船舶航行及注意力/反应时间的影响。
Int J Occup Environ Health. 2008 Oct-Dec;14(4):250-6. doi: 10.1179/oeh.2008.14.4.250.
4
[Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].[在规定加速条件下含东莨菪碱的贴膜与茶苯海明的飞行对比研究]
Arzneimittelforschung. 1986 Sep;36(9):1401-6.
5
Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.用于预防晕动病的透皮东莨菪碱:临床药代动力学及治疗应用
Clin Pharmacokinet. 2006;45(6):543-66. doi: 10.2165/00003088-200645060-00001.
6
Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.抗晕动病药物对健康男性主观嗜睡及认知表现影响的评估
J Psychopharmacol. 2014 Jul;28(7):655-64. doi: 10.1177/0269881113516201. Epub 2013 Dec 17.
7
Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance--a randomized, double-blind, 3-way crossover study in healthy volunteers.桂利嗪和茶苯海明抗眩晕复方制剂对事件相关电位、反应时间及精神运动性能的影响——一项在健康志愿者中进行的随机、双盲、三交叉研究
Int J Clin Pharmacol Ther. 2004 Apr;42(4):218-31. doi: 10.5414/cpp42218.
8
A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.桂利嗪与东莨菪碱治疗晕船疗效的比较。
Aviat Space Environ Med. 1994 Jul;65(7):597-605.
9
Safety of double-dose transdermal scopolamine.双倍剂量透皮东莨菪碱的安全性。
Pharmacotherapy. 2009 Sep;29(9):1082-8. doi: 10.1592/phco.29.9.1082.
10
Vestibular evoked myogenic potentials and motion sickness medications.前庭诱发肌源性电位与晕动病药物
Clin Neurophysiol. 2016 Jun;127(6):2350-4. doi: 10.1016/j.clinph.2016.03.010. Epub 2016 Mar 19.

引用本文的文献

1
Motion Syros: tradipitant effective in the treatment of motion sickness; a multicenter, randomized, double-blind, placebo-controlled study.Motion Syros:曲哌立吞对晕动病治疗有效;一项多中心、随机、双盲、安慰剂对照研究。
Front Neurol. 2025 Mar 4;16:1550670. doi: 10.3389/fneur.2025.1550670. eCollection 2025.
2
Nutritional and Behavioral Countermeasures as Medication Approaches to Relieve Motion Sickness: A Comprehensive Review.营养和行为对策作为缓解晕动病的药物方法:全面综述。
Nutrients. 2023 Mar 7;15(6):1320. doi: 10.3390/nu15061320.
3
Antihistamines for motion sickness.
抗组胺药治疗晕动病。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD012715. doi: 10.1002/14651858.CD012715.pub2.
4
Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.偏头痛的药物治疗与认知障碍:风险与获益。
Int J Mol Sci. 2022 Sep 27;23(19):11418. doi: 10.3390/ijms231911418.
5
Simultaneous estimation of dimenhydrinate, cinnarizine and their toxic impurities benzophenone and diphenylmethylpiperazine; toxicity profiling of impurities.同时测定茶苯海明、桂利嗪及其有毒杂质二苯甲酮和二苯基甲基哌嗪;杂质的毒性分析。
RSC Adv. 2020 Oct 9;10(61):37439-37448. doi: 10.1039/d0ra06147f. eCollection 2020 Oct 7.
6
Otorhinolaryngological adverse effects of urological drugs.泌尿科药物的耳鼻喉不良反应。
Int Braz J Urol. 2021 Jul-Aug;47(4):747-752. doi: 10.1590/S1677-5538.IBJU.2021.99.06.
7
Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study.曲哌立坦治疗晕动病:一项随机、双盲、安慰剂对照研究。
Front Neurol. 2020 Sep 29;11:563373. doi: 10.3389/fneur.2020.563373. eCollection 2020.
8
Motion sickness: an overview.晕动病:概述
Drugs Context. 2019 Dec 13;8. doi: 10.7573/dic.2019-9-4. eCollection 2019.
9
Motion sickness: more than nausea and vomiting.晕动病:不止恶心与呕吐。
Exp Brain Res. 2014 Aug;232(8):2493-510. doi: 10.1007/s00221-014-4008-8. Epub 2014 Jun 25.
10
Relating drug-protein interaction network with drug side effects.将药物-蛋白相互作用网络与药物副作用相关联。
Bioinformatics. 2012 Sep 15;28(18):i522-i528. doi: 10.1093/bioinformatics/bts383.